Preoperative carcinoembryonic antigen and albumin in predicting survival in patients with colon and rectal carcinomas

Journal of Clinical Gastroenterology

Volumn 40, Issue 7, 2006, Pages 592-595

  Boonpipattanapong, Teeranut ^a   Chewatanakornkul, Siripong ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

Albumin; Carcinoembryonic antigen; Colon carcinoma; Rectal carcinoma; Survival

Indexed keywords

ALBUMIN; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; COHORT ANALYSIS; COLON CARCINOMA; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RECTUM CARCINOMA; RETROSPECTIVE STUDY; TUMOR DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; CELL DIFFERENTIATION; COLONIC NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; SERUM ALBUMIN; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS;

EID: 33747454617     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200608000-00006     Document Type: Article

References (14)

1. Duffy MJ. Carcinoembryonic antigen as a marker for colorectal cancer: Is it clinically useful? Clin Chem. 2001;47:624-630.
2. Chan DW, Sell S. Specific tumor markers. In: Burtis CA, Ashwood ER, eds. Tietz Textbook of Clinical Chemistry. Philadelphia, PA: WB Saunders Company; 1999:727-748.
3. Mitchell EP. Role of carcinoembryonic antigen in the management of advanced colorectal cancer. Semin Oncol. 1998;25:12-20.
4. Fletcher RH. Carcinoembryonic antigen. Ann Int Med. 1986;104:66-73.
5. Bast RC, Ravdin P, Hayes DF, et al. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol. 2001;19:1865-1878.
6. Schwartz MK. Tumor markers. In: McClatchey KD, ed. Clinical Laboratory Medicine. Philadelphia, PA: Lippincott Williams & Wilkins; 2002:489-498.
7. Compton C, Fenoglio-Preiser CM, Pettigrew N, et al. American Joint Committee on Cancer Prognostic Factor Consensus Conference. Cancer. 2000;88:1739-1757.
8. Dixon MR, Haukoos JS, Udani SM, et al. Carcinoembryonic antigen and albumin predict survival in patients with advanced colon and rectal cancer. Arch Surg. 2003;138:962-966.
9. Greene FL, Page DL, Fleming ID, et al. eds. AJCC Cancer Staging Manual Staging Forms. 6th ed. New York: Springer-Verlag; 2002.
10. Crawford NPS, Colliver DW, Galandiuk S. Tumor markers and colorectal cancer: utility in management. J Surg Oncol. 2003;84:239-248.
11. Kutun S, Celik A, Hatiboglu C, et al. Carcinoembryonic antigen to detect hepatic metastases of colorectal cancers. Surg Today. 2003;33:590-594.
12. Watine J, Miedouge M, Friedberg B. Carcinoembryonic antigen as an independent prognostic factor of recurrence and survival in patients resected for colorectal liver metastases; a systematic review. Dis Colon Rectum. 2001;44:1791-1799.
13. Wang WS, Lin JK, Chiou TJ, et al. Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer: Taiwan experience. Jpn J Clin Oncol. 2000;30:12-16.
14. Diez M, Pollan M, Muguerza JM, et al. Time-dependency of the prognostic effect of carcinoembryonic antigen and p53 protein in colorectal adenocarcinoma. Cancer. 2000;88:35-41.